GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MeVis Medical Solutions AG (XTER:M3V) » Definitions » Capex-to-Revenue

MeVis Medical Solutions AG (XTER:M3V) Capex-to-Revenue : 0.00 (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is MeVis Medical Solutions AG Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

MeVis Medical Solutions AG's Capital Expenditure for the six months ended in Mar. 2024 was €0.00 Mil. Its Revenue for the six months ended in Mar. 2024 was €8.77 Mil.

Hence, MeVis Medical Solutions AG's Capex-to-Revenue for the six months ended in Mar. 2024 was 0.00.


MeVis Medical Solutions AG Capex-to-Revenue Historical Data

The historical data trend for MeVis Medical Solutions AG's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MeVis Medical Solutions AG Capex-to-Revenue Chart

MeVis Medical Solutions AG Annual Data
Trend Dec13 Dec14 Dec15 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 - 0.01 0.01

MeVis Medical Solutions AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of MeVis Medical Solutions AG's Capex-to-Revenue

For the Health Information Services subindustry, MeVis Medical Solutions AG's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MeVis Medical Solutions AG's Capex-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where MeVis Medical Solutions AG's Capex-to-Revenue falls into.



MeVis Medical Solutions AG Capex-to-Revenue Calculation

MeVis Medical Solutions AG's Capex-to-Revenue for the fiscal year that ended in Sep. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.08) / 17.342
=0.00

MeVis Medical Solutions AG's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 8.774
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MeVis Medical Solutions AG  (XTER:M3V) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


MeVis Medical Solutions AG Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of MeVis Medical Solutions AG's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


MeVis Medical Solutions AG (XTER:M3V) Business Description

Traded in Other Exchanges
Address
Caroline-Herschel-Strasse 1, Bremen, DEU, 28359
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.

MeVis Medical Solutions AG (XTER:M3V) Headlines

No Headlines